Home > Insider Trading > Filing (0001209191-22-062641)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087294	Cumberland Pharmaceuticals Inc	CPIX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1695580	Kenneth Krogulski	2525 West End Avenue Suite 950 Nashville TN 37203		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-11-01	105	$2.53	199,805	No	4	P	Direct
Common Stock	Acquisiton	2022-11-02	105	$2.54	199,910	No	4	P	Direct
Common Stock	Acquisiton	2022-11-03	105	$2.44	200,015	No	4	P	Direct
Common Stock	Acquisiton	2022-11-04	105	$2.42	200,120	No	4	P	Direct
Common Stock	Acquisiton	2022-11-07	105	$2.45	200,225	No	4	P	Direct
Common Stock	Acquisiton	2022-11-08	105	$2.42	200,330	No	4	P	Direct
Common Stock	Acquisiton	2022-11-09	105	$2.37	200,435	No	4	P	Direct
Common Stock	Acquisiton	2022-11-10	105	$2.37	200,540	No	4	P	Direct
Common Stock	Acquisiton	2022-11-11	105	$2.32	200,645	No	4	P	Direct
Common Stock	Acquisiton	2022-11-14	105	$2.32	200,750	No	4	P	Direct
Common Stock	Acquisiton	2022-11-15	105	$2.35	200,855	No	4	P	Direct
Common Stock	Acquisiton	2022-11-16	105	$2.31	200,960	No	4	P	Direct
Common Stock	Acquisiton	2022-11-17	105	$2.29	201,065	No	4	P	Direct
Common Stock	Acquisiton	2022-11-18	105	$2.27	201,170	No	4	P	Direct
Common Stock	Acquisiton	2022-11-21	105	$2.38	201,275	No	4	P	Direct
Common Stock	Acquisiton	2022-11-22	105	$2.37	201,380	No	4	P	Direct
Common Stock	Acquisiton	2022-11-23	105	$2.29	201,485	No	4	P	Direct
Common Stock	Acquisiton	2022-11-25	105	$2.31	201,590	No	4	P	Direct
Common Stock	Acquisiton	2022-11-28	105	$2.37	201,695	No	4	P	Direct
Common Stock	Acquisiton	2022-11-29	105	$2.34	201,800	No	4	P	Direct
Common Stock	Acquisiton	2022-11-30	105	$2.32	201,905	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.